Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 328.39 | 40.21 |
| PEG Ratio (TTM) | -2.36 | 0.19 |
| P/S Ratio (TTM) | 1.79 | 3.35 |
| P/B Ratio (TTM) | 0.52 | 0.74 |
| P/FCF Ratio (TTM) | 4.89 | -57.26 |
| Price to 5YR AVG Earnings Ratio | 9.98 | 70.57 |
| Price to 5YR AVG FCF Ratio | 5.61 | 5.86 |
Profitability (18%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.03% | 0.79% |
| ROE (TTM) | 0.16% | 6.20% |
| Net Profit Margin (TTM) | 0.54% | 26.96% |
| ROIC 5YR AVG | 1.61% | 5.03% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 109.18% | 29.65% | -87.97% |
| Revenue | 46.66% | 15.80% | 13.27% |
| Net Income | 160.39% | 37.63% | -28.06% |
| Cash Flow | 7.73% | 17.76% | 15.34% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.95 | 5.83 |
| Quick Ratio (TTM) | 2.95 | 5.77 |
| D/E Ratio (TTM) | 3.90 | 2.59 |
| Interest Coverage (TTM) | 0.57 | 0.18 |
| Piotroski F-Score | 5 | 4 |
| Altman Z-Score | 0.29 | 0.42 |
| LTL to 5YR AVG FCF | 48.22 | 8.39 |
| Shares Outstanding Growth 5YR AVG | 4.90% | 10.76% |